Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06516731 · ClinicalTrials.gov registry record · NA

A Single Group Study to Evaluate the Effects of a pH Balanced Cleanser on Women's Intimate Health.

A NA study, sponsored by Love Wellness.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT06516731: Completed NA study, sponsored by Love Wellness.

NCT06516731 is a NA study that has completed, run by Love Wellness. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06516731, a NA study, has completed, sponsored by Love Wellness.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This virtual single-group study will last 8 weeks, involving the daily use of a pH Balanced Cleanser by 40 female participants. The study aims to evaluate the effect of the cleanser on signs of vulvar and vaginal health and its tolerability.

Primary Outcome

Parameters associated with vulvar and vaginal health, including odor and pH levels, will be evaluated. Participants will complete questionnaires at Baseline, first use, Week 2, Week 4, Week 6, and Week 8.

Interventions

  • DIETARY_SUPPLEMENT pH Balanced Cleanser

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-02-09
Est. Completion 2024-06-03
Phase NA
Love Wellness

6 total trials

What the finished NCT06516731 record still lists

NCT06516731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which pH Balanced Cleanser is the first listed.

NCT06516731 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06516731 about?

NCT06516731 is a clinical study titled "A Single Group Study to Evaluate the Effects of a pH Balanced Cleanser on Women's Intimate Health.". This virtual single-group study will last 8 weeks, involving the daily use of a pH Balanced Cleanser by 40 female participants. The study aims to evaluate the effect of the cleanser on signs of vulvar and vaginal health and its tolerability.

What is the current status of trial NCT06516731?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-02-09. Estimated completion is 2024-06-03.

What interventions are being tested in trial NCT06516731?

The interventions under investigation include: pH Balanced Cleanser (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06516731?

This trial is sponsored by Love Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06516731's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06516731, the US trial registry maintained by the National Library of Medicine. NCT06516731 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.